The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
NRXS · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
MEHA · Healthcare · Narrow moat
Wonderful & reasonably priced
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | NRXS | LGND | MEHA | TDY |
|---|---|---|---|---|
| Moat Score (0–100) | 64 (highest) | 64 (highest) | 64 (highest) | 64 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 57 | 65 | 66 | 90 (highest) |
| Pricing power | 100 (highest) | 100 (highest) | 90 | 65 |
| Returns on capital | — | 20 | — | 25 (highest) |
| Balance-sheet safety | 55 | 44 | 55 | 79 (highest) |
| Capital allocation | 44 | 91 (highest) | 44 | 60 |
| No price data | 528% above value if growth stopped today | 94% below value if growth stopped today (largest discount to value if growth stopped today) | 161% above value if growth stopped today | |
| Market cap | $72.4M | $5.9B | $86041 | $30.3B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |